2017 Gastroenterology and Hepatology Symposium

Transcription

1 2017 Gastroenterology and Hepatology Symposium Frontiers in Gastrointestinal and Liver Disease February 11, 2017 Royal Sonesta Houston Conference Room 2222 West Loop South, Houston TX 77027

2 2017 HIGHLIGHTS Topics of Interest in Colonic Disease and IBD New Perspective in Luminal Gastroenterology Advanced Endoscopy in 2017 Controversies in Liver Disease COURSE DIRECTORS Moises I. Nevah, M.D. Transplant Hepatology, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center, McGovern Medical School at UTHealth Nirav Thosani, M.D., M.H.A. Director of Advanced Therapeutic Endoscopy Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center, McGovern Medical School at UTHealth

3 FRONTIERS IN GASTROINTESTINAL INVITED FACULTY SPEAKERS Subhas Banerjee, M.D. Director of Endoscopy, Associate Professor of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine Michael B. Fallon, M.D. Professor, Executive Director for Clinical Research and Chair of Department of Medicine, University of Arizona College of Medicine-Phoenix, Banner University Medical Group Gary R. Lichtenstein, M.D. Director, Center for Inflammatory Bowel Disease, University of Pennsylvania Health System Professor of Medicine, Division of Gastroenterology,, Perelman School of Medicine of the University of Pennsylvania Arun Sanyal, M.D. Professor of Medicine, Physiology and Molecular Pathology, Virginia Commonwealth University School of Medicine Brennan M. Spiegel, M.D., M.S.H.S. Director of Health Services Research, Director of the Center for Outcomes Research and Education, Cedars-Sinai Health System Professor-in-Residence of Medicine and Public Health, David Geffen School of Medicine at UCLA 1

4 FRONTIERS IN GASTROINTESTINAL McGOVERN MEDICAL SCHOOL AT UTHEALTH FACULTY SPEAKERS John S. Bynon, M.D. Chief of Abdominal Transplant, Memorial Hermann-Texas Medical Center Director, Professor of Immunology and Organ Transplant, Department of Surgery Marc Catalano, M.D. Medical Director of Advanced Endoscopy Fellowship Professor, Division of Gastroenterology, Hepatology and Nutrition, Reena V. Chokshi, M.D. Abhishek Choudhary, M.D. Andrew Dupont, M.D. Director, Inflammatory Bowel Disease, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center Associate Professor, Director of Clinical Investigation in Gastroenterology, and Director of Gastroenterology Fellowship, Division of Gastroenterology, Hepatology and Nutrition, Atilla Ertan, M.D. Director, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center Professor and Interim Chief of Service, Division of Gastroenterology, Hepatology and Nutrition, Sushovan Guha, M.D., Ph.D. Director of Gastroenterology and Hepatology Outcomes, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center Associate Professor, Director of Research and Associate Director of Gastroenterology Fellowship, Division of Gastroenterology, Hepatology and Nutrition, 2

5 FRONTIERS IN GASTROINTESTINAL McGOVERN MEDICAL SCHOOL AT UTHEALTH FACULTY SPEAKERS Victor Machicao, M.D. Medical Director of Liver Transplantation, Memorial Hermann-Texas Medical Center Associate Professor, Division of Gastroenterology, Hepatology and Nutrition, Erik Rahimi, M.D. Jennifer Shroff, M.D. Staff Physician, Division of Gastroenterology, Hepatology and Nutrition, Shashideep Singhal, M.D. Erik Wilson, M.D., FACS Medical Director of Bariatric Surgery, Memorial Hermann-Texas Medical Center Professor, Vice Chair and Division Director of Minimally Invasive and Elective Surgery, Department of Surgery Mamoun Younes, M.D. Director of Gastrointestinal and Liver Pathology Services, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center Professor, Department of Pathology and Laboratory Medicine Hani Zamil, M.D. Director of Gastrointestinal Motility and Physiology, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center 3

6 FRONTIERS IN GASTROINTESTINAL 7:30 a.m. Breakfast and Registration TOPICS OF INTEREST IN COLONIC DISEASE AND IBD Moderators: Andrew Dupont, M.D., and Jennifer Shroff, M.D. 8:00 a.m. Quality in Endoscopy: Can We Do Better? Erik Rahimi, M.D. 8:20 a.m. Management of the Pregnant IBD Patient Jennifer Shroff, M.D. 8:40 a.m. Biologics and Biosimilars: Present and Future Atilla Ertan, M.D. 9:00 a.m. Emerging Role of Fecal Transplant in Various Gastrointestinal Diseases Andrew Dupont, M.D. 9:20 a.m. What to Do When Biological Therapy Doesn t Work in IBD Patients? Gary R. Lichtenstein, M.D. 9:40 a.m. Q&A 10:00 a.m. Break NEW PERSPECTIVE IN LUMINAL GASTROENTEROLOGY Moderators: Sushovan Guha, M.D., Ph.D., and Hani Zamil, M.D. 10:10 a.m. The Smart Pill Where Does It Stand in GI Motility? Reena Chokshi, M.D. 10:30 a.m. What to Do with Difficult to Manage GERD? Hani Zamil, M.D. 10:50 a.m. Advanced Optical Imaging Technique: From Barrett s Esophagus to Colon Polyps Abhishek Choudhary, M.D. 11:10 a.m. Management to Anticoagulation and Antiplatelet Agents Prior to Endoscopy Sushovan Guha, M.D., Ph.D. 11:30 a.m. Cutting the Wheat from the Chaff: Diagnostic Testing in IBS Brennan Spiegel, M.D., M.S.H.S. 11:50 a.m. Q&A 12:10 p.m. Lunch 4

7 FRONTIERS IN GASTROINTESTINAL ADVANCED ENDOSCOPY 2017 Moderators: Marc Catalano, M.D., and Nirav Thosani, M.D. 1:00 p.m. Endoscopic Management of GERD Erik Wilson, M.D., FACS 1:20 p.m. Endoscopic Management of the Obese Patient Marc Catalano, M.D. 1:40 p.m. Closing the Gaps: Endoscopic Management of Perforations Shashideep Singhal, M.D. 2:00 p.m. Beyond the Lumen: Interventional EUS Nirav Thosani, M.D., M.H.A. 2:20 p.m. Choledoschoscopy: Past, Present and Future Subhas Banerjee, M.D. 2:40 p.m. Q&A 3:00 p.m. Break CONTROVERSIES IN LIVER DISEASE Moderators: Victor Machicao, M.D., and Moises I. Nevah, M.D. 3:10 p.m. Region 4 Liver Transplantation: The Good, The Bad, and The Ugly John S. Bynon, M.D. 3:30 p.m. Can We Cure Hepatitis B? Victor Machicao, M.D. 3:50 p.m. Is Cirrhosis Reversible? Yes and No! Michael B. Fallon, M.D., and Mamoun Younes, M.D. 4:10 p.m. Is There a Difficult-to-Treat HCV Patient in Today s Era? Moises I. Nevah, M.D. 4:30 p.m. Is Treatment Necessary for All Patients with Non-Alcoholic Fatty Liver Disease? (NAFLD) Arun Sanyal, M.D. 4:50 p.m. Q&A 5:10 p.m. Adjourn 5

8 FRONTIERS IN GASTROINTESTINAL DATE February 11, 2017 LOCATION Royal Sonesta Houston, Conference Room 2222 West Loop South Houston, TX COURSE DESCRIPTION The Gastroenterology and Hepatology Symposium is a one-day course designed to educate physicians and other healthcare professionals on how to optimally manage patients, using a team approach. EDUCATIONAL OBJECTIVES At the conclusion of this activity, the participant should be able to: Highlight currently proposed endoscopic quality guidelines. Discuss the practical issues and management of IBD in pregnancy. Formulate an evidence-based approach to IBD by utilizing new therapies. Discuss fecal transplantation in current GI practice. Understand management options for IBD patients beyond biological treatment. Understand the diagnostic workup and management of difficult-to-treat GERD. Understand the current guidelines for preprocedure management of patients on anticoagulation and antiplatelet agents. Describe the GI motility disorders in which the smart pill has found diagnostic applicability. Describe the different endoscopic imaging techniques for the detection of dysplasia in Barrett s esophagus, and detection of adenoma within colon polyps. Enumerate different tests currently being used to support diagnosis of IBS, including recently revised ROME IV criteria. Discuss the current endoscopic techniques for the management of GERD. Describe endoscopic treatment that serves as adjuvant therapy or alternative surgery. Identify the indications and role of advanced endoscopic techniques in interventional EUS. Discuss endoscopic methods for management of perforations, leaks and fistulae. Identify the current indications and role of choledoschoscopy in management of biliary and pancreatic diseases. Enumerate the mechanism by which Hepatitis B can be cured. List the difficult-to-treat hepatitis C patient groups and the new oral agents accepted for their treatment. Describe current UNOS Region 4 transplant outcomes. Determine whether liver fibrosis and cirrhosis are reversible. Describe the current diagnostic and treatment approaches for fatty liver disease. AUDIENCE Family practitioners Gastroenterologists Internists 6 Oncologists Nurse practitioners Nurses

9 FRONTIERS IN GASTROINTESTINAL 2017 PLANNING COMMITTEE Moises I. Nevah, M.D., Transplant Hepatology, Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center Assistant Professor, Division of Gastroenterology, Hepatology and Nutrition, McGovern Medical School at UTHealth Nirav Thosani, M.D., M.H.A., Director of Advanced Therapeutic Endoscopy Ertan Digestive Disease Center, Memorial Hermann-Texas Medical Center,, McGovern Medical School at UTHealth Kay Wilkes, B.S.N., RN, Clinical Director of Ertan Digestive Disease Center Deborah Lackey, Associate Vice President of Memorial Hermann Foundation Marissa Beasley, Program Coordinator, Memorial Hermann Foundation Katie Shak, Physician Liaison, Office of the CEO, Memorial Hermann-Texas Medical Center Shelby Pulverenti, Marketing Manager, Memorial Hermann-Texas Medical Center Tina Chen, Marketing Representative, Memorial Hermann-Texas Medical Center Mindy Schultz, Marketing Representative, Memorial Hermann-Texas Medical Center TRAVEL AND HOTEL ACCOMMODATIONS Royal Sonesta Houston, Conference Room 2222 West Loop South Houston, TX Reserve your hotel room early! Booking will end on January 20, 2017, at 5 p.m. CST, or until the designated block of rooms is reserved. The group rate for a single/double is $189. Reserve your room online at sonesta.com/royalhouston, or call and use group code 0210MEMHER. Registration Fees TYPE EARLY BIRD REGISTRATION REGISTRATION (closes Jan. 20th) (closes Feb. 1st) Physicians $75 $95 Nurses & Healthcare Professionals (RNs, PAs, NPs, etc.) $35 $50 To R.S.V.P, please call CARE or find us online at memorialhermann.org/gi-symposium. CME/CNE ACCREDITATION This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Advanced Health Education Center, Ltd. and Memorial Hermann-Texas Medical Center. The Advanced Health Education Center is accredited by the ACCME to provide continuing medical education for physicians. Physicians: The Advanced Health Education Center designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: The Advanced Health Education Center is approved by the California Board of Registered Nursing Provider Number CEP16406 for 8 contact hours. 7

10 Memorial Hermann Health System 7737 Southwest Freeway Houston, TX neuro.memorialhermann.org